Dr. Inman Discusses the Role of Chemotherapy in Bladder Cancer

Brant Inman, MD
Published: Friday, Oct 13, 2017



Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center, discusses the role of chemotherapy in bladder cancer.

Although there have been many trials with chemotherapy combinations, there has not been much progress seen beyond gemcitabine plus cisplatin or with the combination of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC), says Inman.
 


Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center, discusses the role of chemotherapy in bladder cancer.

Although there have been many trials with chemotherapy combinations, there has not been much progress seen beyond gemcitabine plus cisplatin or with the combination of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC), says Inman.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x